Childhood stunting is also stunting South Africa’s economy

Researchers from the University of the Witwatersrand have gathered data from the Diepkloof Forensic Pathology Service in Soweto to better understand why so many women turn to desperate measures instead of seeking legal and safe abortions

The health minister said local investment and support from other global partners would keep the country’s treatment efforts going

Today, people over 50 make up the second largest group of South Africa’s HIV-positive population — 20 years ago, they were the smallest proportion

Victims could see justice as the company begins settlement for the outbreak that was linked to contaminated food

Preeclampsia is a complication characterised by high blood pressure and organ damage, arising during the second half of pregnancy, in labour or in the first week after delivery. It plays a major part in about 16% of the deaths of women in sub-Saharan Africa. And it’s on the rise. The incidence of preeclampsia in Africa […]

Budget cuts, staff shortages and socio-economic barriers continue to undermine efforts to improve neonatal care and reduce infant mortality

Many people told Sarah Stein that practising medicine would be difficult. Now, as a fifth year medical student at the University of Cape Town, she wishes she would have listened more carefully

If all of its National Institutes of Health funding falls away, the country could lose 70% of its medical research capacity

The Anova Health Institute, which received the lion’s share of the US President’s Emergency Plan for Aids funding in South Africa, had its support halted in February along with dozens other nonprofits

Instead of the Aids denialism of decades past, it’s US funding cuts that could lead to up to 300 000 more HIV infections in the next four years. Activists like Sisonke Msimang say the past has answers for the present fight

Scientists warn of a health disaster as high numbers of schoolchildren and university students turn to vaping, despite the dangers

A modelling study released in March gives a clue at which price the jab, lenacapavir, would be worth the health department’s while